EP3058097 - SENSE-ANTISENSE GENE PAIRS FOR PATIENT STRATIFICATION, PROGNOSIS, AND THERAPEUTIC BIOMARKERS IDENTIFICATION [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 25.09.2020 Database last updated on 31.08.2024 | |
Former | Grant of patent is intended Status updated on 07.01.2020 | Most recent event Tooltip | 25.09.2020 | Application deemed to be withdrawn | published on 28.10.2020 [2020/44] | Applicant(s) | For all designated states Agency for Science, Technology and Research 1 Fusionopolis Way 20-10 Connexis Singapore 138632 / SG | [2016/34] | Inventor(s) | 01 /
GRINCHUK, Oleg c/o Bioinformatics Institute 30 Biopolis Street 07-01 Matrix Singapore 138671 / SG | 02 /
MOTAKIS, Efthimios c/o Bioinformatics Institute 30 Biopolis Street 07-01 Matrix Singapore 138671 / SG | 03 /
YENAMANDRA, Surya Pavan c/o Bioinformatics Institute 30 Biopolis Street 07-01 Matrix Singapore 138671 / SG | 04 /
KUZNETSOV, Vladimir Andreevich c/o Bioinformatics Institute 30 Biopolis Street 07-01 Matrix Singapore 138671 / SG | [2016/34] | Representative(s) | Williams, Andrea Marks & Clerk LLP 62-68 Hills Road Cambridge CB2 1LA / GB | [2016/34] | Application number, filing date | 14853366.4 | 20.10.2014 | [2016/34] | WO2014SG00492 | Priority number, date | SG20130007917 | 18.10.2013 Original published format: SG 201307917 | [2016/34] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2015057169 | Date: | 23.04.2015 | Language: | EN | [2015/16] | Type: | A1 Application with search report | No.: | EP3058097 | Date: | 24.08.2016 | Language: | EN | The application published by WIPO in one of the EPO official languages on 23.04.2015 takes the place of the publication of the European patent application. | [2016/34] | Search report(s) | International search report - published on: | AU | 23.04.2015 | (Supplementary) European search report - dispatched on: | EP | 29.09.2017 | Classification | IPC: | G16B40/20, G16B25/10 | [2019/46] | CPC: |
G16B25/10 (EP,US);
C12Q1/6886 (EP,US);
G16B20/00 (EP,US);
G16B20/20 (EP,US);
G16B25/00 (US);
G16B35/00 (EP,US);
G16B40/00 (EP,US);
G16B40/20 (EP,US);
G16C20/60 (EP,US);
|
Former IPC [2017/30] | G06F19/18, C12Q1/68 | ||
Former IPC [2016/34] | C12Q1/68, G06F17/18 | Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2016/34] | Title | German: | SENSE-ANTISENSE-GENPAARE FÜR PATIENTENSCHICHTUNG UND -PROGNOSE SOWIE IDENTIFIKATION THERAPEUTISCHER BIOMARKER | [2016/34] | English: | SENSE-ANTISENSE GENE PAIRS FOR PATIENT STRATIFICATION, PROGNOSIS, AND THERAPEUTIC BIOMARKERS IDENTIFICATION | [2016/34] | French: | PAIRES DE GÈNES SENS-ANTISENS POUR LA STRATIFICATION DE PATIENTS, LE PRONOSTIC ET L'IDENTIFICATION DE BIOMARQUEURS THÉRAPEUTIQUES | [2016/34] | Entry into regional phase | 10.05.2016 | National basic fee paid | 10.05.2016 | Search fee paid | 10.05.2016 | Designation fee(s) paid | 10.05.2016 | Examination fee paid | Examination procedure | 14.08.2015 | Request for preliminary examination filed International Preliminary Examining Authority: AU | 10.05.2016 | Examination requested [2016/34] | 20.03.2018 | Amendment by applicant (claims and/or description) | 08.01.2020 | Communication of intention to grant the patent | 03.06.2020 | Application deemed to be withdrawn, date of legal effect [2020/44] | 24.06.2020 | Despatch of communication that the application is deemed to be withdrawn, reason: renewal fee not paid in time [2020/44] | Fees paid | Renewal fee | 11.10.2016 | Renewal fee patent year 03 | 25.10.2017 | Renewal fee patent year 04 | 11.10.2018 | Renewal fee patent year 05 | Penalty fee | Additional fee for renewal fee | 31.10.2019 | 06   M06   Not yet paid |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [XP] - Oleg V Grinchuk ET AL, "Sense-antisense gene-pairs in breast cancer and associated pathological pathways", Oncotarget, United States, (20151208), page 42197, URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4747219/pdf/oncotarget-06-42197.pdf, (20170612), XP055380726 [XP] 1-5,15 * the whole document * DOI: http://dx.doi.org/10.18632/oncotarget.6255 | International search | [X]WO2010104472 (AGENCY SCIENCE TECH & RES [SG], et al); | [X]WO2010104474 (AGENCY SCIENCE TECH & RES [SG], et al); | [X]US8435734 (KIYOSAWA HIDENORI [JP], et al); | [XL] - GRINCHUK, O. V. ET AL., "Complex sense-antisense architecture of TNFAIP1/POLDIP2 on 17q11.2 represents a novel transcriptional structural-functional gene module involved in breast cancer progression", BMC GENOMICS, vol. 11, no. 1, (2010), page S9, URL: http://www.biomedcentral.com/content/pdf/1471-2164-11-S1-S9.pdf, (20150106), XP055064273 DOI: http://dx.doi.org/10.1186/1471-2164-11-S1-S9 | [XL] - GRINCHUK, O ET AL., "Identification of complex sense-antisense gene 's module on 17q11.2 associated with breast cancer aggressiveness and patient's survival", WORLD ACADEMY OF SCIENCE , ENGINEERING AND TECHNOLOGY, (2009), vol. 58, pages 1046 - 1056, XP009169914 |